Surgical treatment for periacetabular metastatic lesions
Adult
Male
Complications
Bone Cements -- therapeutic use
Operative Time
Blood Loss, Surgical
Bone Neoplasms
Metastasis
Pelvis
Curettage
03 medical and health sciences
Postoperative Complications
0302 clinical medicine
Surgical
80 and over
Humans
Blood Loss
Curettage -- adverse effects
Reconstructive Surgical Procedures
Adjuvant
Aged
Pain Measurement
Retrospective Studies
Postoperative Complications -- etiology
Aged, 80 and over
Pelvic surgery
Radiotherapy
Cancer Pain -- etiology -- therapy
Bone Cements
Acetabulum
Cancer Pain
Middle Aged
Plastic Surgery Procedures
Bone Neoplasms -- complications -- radiotherapy -- secondary -- surgery
3. Good health
Survival Rate
Orthopédie
Female
Radiotherapy, Adjuvant
DOI:
10.1016/j.ejso.2017.03.018
Publication Date:
2017-04-08T16:47:05Z
AUTHORS (3)
ABSTRACT
Periacetabular bone metastasis present with severe pain and functional loss leading to a poor quality of life. Surgical treatment remains challenging.We reviewed all cases operated at our institution. We analyzed pain scores and functional status as well as complications and their risk factors.Thirty-five patients underwent curettage and cemented reconstruction. Mean surgical time was 168 min. Mean surgical blood losses were 3150 ml. Major complications were encountered in 23% and minor complications in 29% of cases. We found a significant pain relief (p < 0.0001) and improvement in functional status in the postoperative period (p < 0.0001). A Harrington grade 4 lesion was correlated with a higher complication rate (p-value = 0.002).In this series we were able to show that surgical management is an effective option in the treatment of metastatic bone disease to the pelvis. However, this treatment is very complex and associated with very high complication rates. Therefore, adequate patient selection and preoperative management is advocated.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (15)
CITATIONS (16)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....